| Original language | English (US) |
|---|---|
| Pages (from-to) | 630-631 |
| Number of pages | 2 |
| Journal | Journal of the American College of Cardiology |
| Volume | 59 |
| Issue number | 6 |
| DOIs | |
| State | Published - Feb 7 2012 |
| Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Differences in treatment patterns and outcomes between hispanics and non-hispanic whites treated for ST-segment elevation myocardial infarction : Results from the NCDR ACTION registry-GWTG. / Guzman, Luis A.; Li, Shuang; Wang, Tracy Y. et al.
In: Journal of the American College of Cardiology, Vol. 59, No. 6, 07.02.2012, p. 630-631.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Differences in treatment patterns and outcomes between hispanics and non-hispanic whites treated for ST-segment elevation myocardial infarction
T2 - Results from the NCDR ACTION registry-GWTG
AU - Guzman, Luis A.
AU - Li, Shuang
AU - Wang, Tracy Y.
AU - Daviglus, Martha L.
AU - Exaire, Jose
AU - Rodriguez, Carlos J.
AU - Torres, Vilma I.
AU - Funk, Marjorie
AU - Saucedo, Jorge
AU - Granger, Chris
AU - Pia, Ileana L.
AU - Cohen, Mauricio G.
N1 - Funding Information: Please note: This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR). The views expressed in this paper represent those of the author(s), and do not necessarily represent the official views of the NCDR or its associated professional societies identified at www.ncdr.com . ACTION Registry–GWTG is an initiative of the American College of Cardiology Foundation and the American Heart Association with partnering support from the Society of Chest Pain Centers, the American College of Emergency Physicians, and the Society of Hospital Medicine. The registry is sponsored in part by the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. Dr. Guzman is a consultant receiving honorarium from AstraZeneca and Merit Medical. Dr. Wang has received support from BMS/Sanofi Partnership, Lilly/Daiichi Partnership, The Medicines Co., Schering (now Merck), Canyon Pharmaceuticals, Heartscape, Medco, and AstraZeneca. Dr. Torres is on the Speaker's Bureau for Sanofi Aventis, Novartis, and Boehringer. Dr. Saucedo is on the advisory board of and has received honoraria and research grants from Eli Lilly and Merck . Dr. Granger has received support from Astellas Pharma, AstraZeneca, Sanofi-Aventis, The Medicines Co., Boehringer Ingelheim, GlaxoSmithKline, Hoffmann-La Roche, Medtronic Foundation, Merck & Co., Novartis, Otsuka, and Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2012/2/7
Y1 - 2012/2/7
UR - http://www.scopus.com/inward/record.url?scp=84863049047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863049047&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2011.10.882
DO - 10.1016/j.jacc.2011.10.882
M3 - Letter
C2 - 22300700
AN - SCOPUS:84863049047
VL - 59
SP - 630
EP - 631
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 6
ER -